Cognitive Decline in Hemodialysis Patients: A Cross-Sectional Study Using Addenbrooke's Cognitive Examination-III

Siri Chandana1, Jayakumar M1, Sandhya Suresh1

  • 1Department of Nephrology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.

Cureus
|October 17, 2025
PubMed

Insights

Cognitive impairment affects nearly half of hemodialysis patients in South India, particularly impacting memory and attention. Early screening using ACE-III is recommended for timely interventions in chronic kidney disease care.

Area of Science:

  • Nephrology
  • Neurology
  • Psychology

Background:

  • Cognitive impairment (CI) is a common, often undiagnosed complication in patients undergoing maintenance hemodialysis (HD).
  • Understanding the prevalence and patterns of CI in diverse populations like South India is crucial for effective management.
  • The Addenbrooke's Cognitive Examination-III (ACE-III) offers a comprehensive tool for assessing cognitive function.

Purpose of the Study:

  • To determine the prevalence and patterns of cognitive dysfunction among South Indian patients on maintenance hemodialysis.
  • To identify clinical and sociodemographic factors associated with cognitive impairment in this population.
  • To evaluate the utility of the ACE-III for screening cognitive impairment in HD patients.

Main Methods:

  • A cross-sectional study involving 175 maintenance hemodialysis patients in Chennai, Tamil Nadu, India.
  • Cognitive function was assessed using the Indian English version of the Addenbrooke's Cognitive Examination-III (ACE-III).
  • Data on age, gender, education, dialysis duration, comorbidities, and hemoglobin levels were collected and analyzed.

Main Results:

  • Cognitive impairment was identified in 46.9% (82 out of 175) of the patients, with ACE-III scores between 60-80.
  • Lower cognitive scores significantly correlated with older age, lower educational attainment, and longer duration of dialysis (p<0.05).
  • Memory and attention domains were most frequently affected by cognitive dysfunction.

Conclusions:

  • Cognitive impairment is highly prevalent in the South Indian hemodialysis population, with significant associations with age, education, and dialysis duration.
  • Routine screening with ACE-III can aid in the early detection of cognitive impairment in hemodialysis patients.
  • Targeted interventions based on early detection can improve outcomes for cognitive dysfunction in chronic kidney disease patients undergoing dialysis.

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
770
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
547
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
233
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
733
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
335